Silicon Valley K-MOVE Career Fair (June 9, 2021, 5:00 PM PST)

Topic

실리콘밸리K-MOVE 기술인력 커리어페어 (Silicon Valley K-Move Virtual Career Fair)



Date and Time

2021년 6월 9일 17:00~18:00 (PST)



Description

주최 : 주샌프란시스코 총영사관, 코트라 실리콘밸리 무역관



Speakers

김은주 UX Desinger @Google

박영희 Senior Director @ SK hynix

김재범 Managing Director @ Samsung Biologics

김영교 Staff Product Designer @ Lyft



Register 


참가신청(eventbrite 사전신청 필수) : https://bit.ly/331K3QY

<취업설명회>

취업설명회에는 글로벌기업 SK hynix, Samsung Biologics, Google, Lyft 의 현직에 계신 관계자분들을 Zoom으로 모시어 실리콘밸리가 원하는 인재상, 글로벌 IT 회사의 채용 과정과 회사 문화 등에 대해 들어보는 시간을 가질 예정이니, 취업을 준비하는 청년들의 많은 관심과 참여 바랍니다!

이번 행사는 사전 신청이 필수 입니다.

eventbrite 통해 등록하시는 분들께 한하여 zoom link를 보내드릴 예정이니 신청 바랍니다.

연사님들께 궁금한 점이 있으시면 질문사항을 kmove@kotrasv.org로 보내주시기 바랍니다.


<취업상담회>


취업설명회와 더불어, 채용을 전제한 1:1 취업상담회도 예정되어 있습니다! 이번 상담회에 참가하는 회사 및 포지션 정보는 아래 케이무브 페이스북을 통해서 확인해보시기 바랍니다.

https://www.facebook.com/kmoveUSAJobs

취업상담회 1:1화상면접을 원하시는 분은, kmove@kotrasv.org로 지원하시는 회사명을 제목에 명기하시어 이력서(+커버레터)를 보내주시기 바랍니다. (예: (Grandlife) 회사지원))

본 행사와 관련하여 궁금한 점이 있으신 분은 코트라 실리콘밸리 무역관 서지원 과장, 김효정 대리에게 연락주시기 바랍니다.  (kmove@kotrasv.org)

감사합니다.

코트라 실리콘밸리 무역관

[AFCR] 2021 BRACE AWARD Venture Competition

The Asian Fund for Cancer Research (AFCR) is pleased to be presenting the 2021 BRACE Award Venture Competition. Semi-finalists will be selected, each of whom will receive widespread exposure and beneficial feedback from a blue-ribbon judging committee. Subject to due diligence and negotiation, the winning company will receive US$300,000 in investment funding from AFCR. Cash awards of US$5,000 and $3,000 will be granted to 2nd and 3rd place competitors, respectively. Click here to download the flyer!

Format & Timeline

  • Submit an online application:
    • Each applicant must submit an online application consisting of summary details, a short video and a presentation deck summarizing the business plan.
    • Application deadline: Tuesday, 1 June 2021, 11:59 PM Hong Kong Time
  • Selection of Semi-Finalists:
    • Submitted applications will be screened by AFCR personnel. Only submissions that demonstrate cancer mitigation technology, business potential and professionalism will be approved.
    • A highly qualified selection committee will review approved applications and determine semi-finalists based on the overall quality of responses.
    • Semi-finalists will be announced over two weeks before the pitch competition, by e-mail communication to all approved applicants and online to general public.
    • Semi-finalists’ short video clips will be voted on by the public in determining the BRACE Award Venture Competition’s “Best Public Communicator” and generating buzz for the event. Cash award of US$2,000 will be grated to the top voted Semi-Finalist!
  • Virtual Competition and Selection of Finalists
    • Semi-finalists chosen are invited to pitch to a judging committee in a series of private presentations on a To Be Determined (TBD) 2021 date—morning, Hong Kong Time. After the conclusion of the pitch competition, top competitors will be highlighted.
    • PowerPoint or PDF presentation formats are required, and must be delivered—verbally and visually—in English. Presenters are required to be available well in advance of their predesignated time slot, and time limit will be strictly enforced.
  • Selection of Winner and Announcement of Investment
    • AFCR will perform detailed due diligence on and communicate with the semi-finalists, in order to determine allocation of US$300,000 in AFCR investment into the business deemed to have the strongest potential for return and cancer patient impact.
    • Announcement of investment will be made in person to the winner at the BIOHK2021, and online to general public.

Eligibility

  • Application must be submitted by a senior executive of an start-up with promising and innovative oncology technologies – therapeutic, diagnostic, preventive, digital health solutions or others – for those cancers prevalent in Asian populations. The individual could be a founder, president, chief executive officer, chief scientific officer, chief medical officer or chief technology officer.
  • Applicant must demonstrate track record of milestone achievement, such as, but not necessarily limited to, government or foundation grants, patents, successful clinical trial phases, commercial exits, etc.
  • No fee to apply.

If you have questions, need more information or are interested in sponsoring this or future BRACE Award Venture Competitions, please contact:

Bradley Gillenwater
AFCR Senior Director of Global Programs & Communications
BGillenwater@AFCR.org

BRACE Award website link

[US FDA] Accepting Applications to the Genomic Science and Health Equity Postdoctoral Fellowship

FDA Office of Minority Health and Health Equity

April 16, 2021

FDA OMHHE - NIH NHGRI Fellowship

Accepting Applications to the Genomic Science and Health Equity Postdoctoral Fellowship

The FDA Office of Minority Health and Health Equity (OMHHE) and the NIH National Human Genome Research Institute (NHGRI) are co-sponsoring a newly established Genomic Science and Health Equity Postdoctoral Fellowship Program.

This program will prepare the fellow to use genetic, genomic and pharmacogenomic approaches to advance minority health and health equity. The fellow will be trained in the research methodology and medical product development processes that facilitate the delivery of drugs, biologics and devices from the bench to the bedside.

The fellow will pursue genomics research related to transfusion support for sickle cell disease (SCD), a health disparity condition that primarily affects African Americans in the United States. The successful candidate will complete a research project to produce reference reagents for blood group genotyping, which will optimize transfusion support for patients with SCD.

Applications are being accepted and will be screened on a rolling basis until the position is filled. The fellow is expected to start in summer or fall 2021.

For more information about this fellowship, visit the Postdoctoral Fellowship in Genomic Science and Health Equity webpage.

https://content.govdelivery.com/accounts/USFDA/bulletins/2cd20a6

[중소벤처기업진흥공단] 미국 바이오헬스 수출현지화 사업 안내

중소벤처기업진흥공단 「미국 바이오헬스 시장 수출현지화 사업」 참여기업 모집 공고

이번에 중진공에서 미국 바이오 헬스현지화 사업 참여기업을 모집하고 있습니다.

한국에 본사가 있고 미국에다가 지사나 법인을 설립한 회사들도 참여대상이 됩니다.  

사업:              미국 바이오 헬스시장 수출 현지화 사업 참여기업 모집

사업목적:         메릴랜드주 바이오헬스 분야 전문기관 (BioHealth Innovation) 활용하여 유망 중소벤처기업의 북미 바이오헬스 시장 진출을 지원

                      마케팅, 제품개선, 시제품 개발, 현지 펀딩, 등 현지화 지원 

참여대상:           K-방역, 의료기기, 디지털헬스케어 (IT 기기, 솔루션) 중소벤처기업. 

지원규모:           5개 회사 

사업기간 및 시기: 20주 온라인 진행.  6월 초 예정 

신청마감:           4월 23일 까지 

신청안내:         첨부된 파일 참고 링크 https://kr.gobizkorea.com/support/app/supportAppInfo.do?svc=e29

사업안내 자료:    https://www.linkedin.com/feed/update/urn:li:activity:6786286558229094401   

6th KAPAL On-Air Webinar (Apr 29, 2021, 9:00 – 10:30 PM EST)

2021 KAPAL–KHIDI Bio & Health Webinar Series #1

When: 04/29/2021, 9:00pm – 10:30pm (EST)
04/29/2021, 6:00pm – 7:30pm(PST)
04/30/2021, 10:00am – 11:30am(KST)

Speaker : Stanford Jhee (Corporate Vice President, Scientific Affairs, Parexel International)

Title: Accelerating Global drug development: Ethnobridging strategies for Asia.

Objectives

  1. Define and understand ethnic sensitivity issues in drug development
  2. Regulatory updates on Japan and China clinical trials and product registration
  3. Clinical pharmacology strategies for identifying ethnicity factors

6th KAPAL On-Air webinar materials will be posted later.